HORMONE REPLACEMENT THERAPY WITH ESTROGEN AND PROGESTOGEN: IMPACT ON WEIGHT AND FAT DISTRIBUTION IN PERI-MENOPAUSAL AND POST-MENOPAUSAL WOMEN
Main Article Content
Keywords
Hormone Replacement Therapy, HRT, Estrogen and Progestogen, Peri-Menopausal, Weight, Post-Menopausal
Abstract
Background: Hormone replacement therapy (HRT) is commonly used to manage menopausal symptoms and prevent bone loss in post-menopausal women. This study evaluates the effects of ‘unopposed estrogen and combined estrogen with progestogen HRT on body weight and fat distribution in peri-menopausal and post-menopausal women’. ‘To assess whether these HRT regimens influence body weight, BMI, waist-to-hip ratio, fat mass, and skinfold thickness’ compared to non-HRT users over six months.
Methods: A randomized controlled trial was conducted with 150 women aged 45 or older at Poonch Medical College and its affiliated Hospital (AJK). Participants were assigned to receive ‘unopposed estrogen HRT, combined estrogen and progestogen HRT’ or no HRT (control). Assessments included baseline and six-month measurements of body composition. Statistical analysis used ANOVA and chi-square tests.
Results: Demographics were similar across groups at baseline. There were no significant differences in weight change, BMI change, ‘waist-to-hip ratio change, fat mass change, or skinfold thickness change between HRT groups and controls (p > 0.05).
Conclusion: Six months of ‘unopposed estrogen or combined estrogen and progestogen HRT did not significantly alter body weight or fat distribution in peri-menopausal and post-menopausal women’. These findings suggest that concerns about substantial weight gain with HRT may be unfounded in the short term. Further research with larger cohorts and longer follow-ups is needed to confirm these results and explore broader health impacts in menopausal women.
References
2. Herskedal V, Indrevåg MS, Rishaug MR. The effect of hormone replacement therapy containing estrogen on muscle strength and muscle mass in postmenopausal women: NTNU; 2022.
3. Porada D, Gołacki J, Matyjaszek-Matuszek B. Obesity in perimenopause—current treatment options based on pathogenetic factors. Endokrynologia Polska. 2023.
4. Gould LM, Gordon AN, Cabre HE, Hoyle AT, Ryan ED, Hackney AC, et al. Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism. Menopause. 2022;29(4):377-89.
5. Black DR, Minkin MJ, Graham S, Bernick B, Mirkin S. Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial. Menopause. 2021;28(1):32-9.
6. Zhang G-Q, Chen J-L, Luo Y, Mathur MB, Anagnostis P, Nurmatov U, et al. Menopausal hormone therapy and women’s health: An umbrella review. PLoS Medicine. 2021;18(8):e1003731.
7. Tseng P-T, Chiu H-J, Suen M-W, Zeng B-S, Wu M-K, Tu Y-K, et al. Pharmacological interventions and hormonal therapies for depressive symptoms in peri-and post-menopausal women: A network meta-analysis of randomized controlled trials. Psychiatry Research. 2023;326:115316.
8. Christakoudi S, Tsilidis KK, Dossus L, Rinaldi S, Weiderpass E, Antoniussen CS, et al. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort. BMC cancer. 2023;23(1):562.
9. Faubion SS, Crandall CJ, Davis L, El Khoudary SR, Hodis HN, Lobo RA, et al. The 2022 hormone therapy position statement of the North American Menopause Society. Menopause. 2022;29(7):767-94.
10. Shih Y-H, Yang C-Y, Wang S-J, Lung C-C. Can Hormone Replacement Therapy Decrease the Likelihood of Diabetes Development in Peri-Menopausal Individuals with Prediabetes? Available at SSRN 4706367.
11. Vigil P, Meléndez J, Petkovic G, Del Río JP. The importance of estradiol for body weight regulation in women. Frontiers in Endocrinology. 2022;13:951186.
12. Steiner BM, Berry DC. The regulation of adipose tissue health by estrogens. Frontiers in Endocrinology. 2022;13:889923.
13. Weidlinger S, Winterberger K, Pape J, Weidlinger M, Janka H, von Wolff M, et al. Impact of estrogens on resting energy expenditure: A systematic review. Obesity Reviews. 2023;24(10):e13605.
14. Juppi H-K, Sipilä S, Cronin NJ, Karvinen S, Karppinen JE, Tammelin TH, et al. Role of menopausal transition and physical activity in loss of lean and muscle mass: a follow-up study in middle-aged Finnish women. Journal of clinical medicine. 2020;9(5):1588.
15. Akter N. Hormone Replacement Therapy and its long-term impact on the survival of women in the United Kingdom: University of East Anglia; 2022.
16. de Souza Santos A, Brito Moreira A, Ribeiro de Souza ML. Prevalence and severity of symptoms in women in menopause: a cross-sectional study. Demetra: Food, Nutrition & Health/Alimentação, Nutrição & Saúde. 2023;18.
17. Depypere H, Vergallo A, Lemercier P, Lista S, Benedet A, Ashton N, et al. Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease. Alzheimer's & Dementia. 2023;19(4):1320-30.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Kalsum Khan
Registrar, Obstetrics and Gynaecology, Letterkenny University Hospital, Ireland
Dr. Alveena Khan
Registrar, Obstetrics and Gynaecology, Letterkenny University Hospital, Ireland
Dr. Aqsa Arbab Khan
SHO Obstetrics and Gynaecology, Letterkenny University Hospital, Ireland
Dr. Reema Gul
Junior Registrar, Obstetrics and Gynaecology, Mardan Medical Complex, MTI Mardan
Dr. Maria Ali Shah
Senior Registrar, Obstetrics and Gynaecology, Liaquat National Hospital, Karachi
Dr. Jahangir Zaib
Assistant Professor Department of Medicine, Poonch Medical College, Rawalakot